Age and gender differences in the urinary proteome of healthy subjects using the advantages of quantitative proteomics

Background Advances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was analyzed using this method to confirm the depth of protein identification and quantitative stability, and to examine changes in abundanc...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental nephrology Vol. 29; no. 7; pp. 912 - 919
Main Authors Yamamoto, Keiko, Yamamoto, Tadashi
Format Journal Article
LanguageEnglish
Published Singapore Springer Nature Singapore 01.07.2025
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Advances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was analyzed using this method to confirm the depth of protein identification and quantitative stability, and to examine changes in abundance with age and sex, as well as the amounts of proteins known to be urinary biomarkers of kidney damage. Methods Urine samples were collected from 89 healthy male and female volunteers in their 20s to 70s. Proteins were precipitated with methanol/chloroform, digested with trypsin, and peptides were identified and quantified by mass spectrometry. The quantitative relative value of a protein in the total protein was multiplied by 1,000,000 to obtain a normalized relative value (ppm). The stability of the quantitative proteomics was examined by measuring quality control samples prepared from healthy volunteer urine mix (HVmix) or diabetic urine mix (DMmix) 5 times in every 20 sample measurements. Results The number of proteins identified was stable at approximately 3000 in five measurements of HVmix and DMmix, as quality control samples. The average coefficient of variation (CV) of the quantitative values was 12.6% for HVmix and 14.8% for DMmix. Approximately 90% of the proteins did not change significantly with age, while approximately 10% of the proteins increased or decreased with age. The quantitative values of some proteins, such as KLK3 in men and A2ML1 in women, differed significantly between the sexes. In addition, several proteins that have already been reported as biomarkers of kidney damage were also quantified. Conclusion(s) This study demonstrated that advanced proteomics enabled comprehensive quantification of urinary proteins, some proteins varied in abundance with age and gender, and provided insight into protein structure.
AbstractList Advances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was analyzed using this method to confirm the depth of protein identification and quantitative stability, and to examine changes in abundance with age and sex, as well as the amounts of proteins known to be urinary biomarkers of kidney damage. Urine samples were collected from 89 healthy male and female volunteers in their 20s to 70s. Proteins were precipitated with methanol/chloroform, digested with trypsin, and peptides were identified and quantified by mass spectrometry. The quantitative relative value of a protein in the total protein was multiplied by 1,000,000 to obtain a normalized relative value (ppm). The stability of the quantitative proteomics was examined by measuring quality control samples prepared from healthy volunteer urine mix (HVmix) or diabetic urine mix (DMmix) 5 times in every 20 sample measurements. The number of proteins identified was stable at approximately 3000 in five measurements of HVmix and DMmix, as quality control samples. The average coefficient of variation (CV) of the quantitative values was 12.6% for HVmix and 14.8% for DMmix. Approximately 90% of the proteins did not change significantly with age, while approximately 10% of the proteins increased or decreased with age. The quantitative values of some proteins, such as KLK3 in men and A2ML1 in women, differed significantly between the sexes. In addition, several proteins that have already been reported as biomarkers of kidney damage were also quantified. This study demonstrated that advanced proteomics enabled comprehensive quantification of urinary proteins, some proteins varied in abundance with age and gender, and provided insight into protein structure.
BackgroundAdvances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was analyzed using this method to confirm the depth of protein identification and quantitative stability, and to examine changes in abundance with age and sex, as well as the amounts of proteins known to be urinary biomarkers of kidney damage.MethodsUrine samples were collected from 89 healthy male and female volunteers in their 20s to 70s. Proteins were precipitated with methanol/chloroform, digested with trypsin, and peptides were identified and quantified by mass spectrometry. The quantitative relative value of a protein in the total protein was multiplied by 1,000,000 to obtain a normalized relative value (ppm). The stability of the quantitative proteomics was examined by measuring quality control samples prepared from healthy volunteer urine mix (HVmix) or diabetic urine mix (DMmix) 5 times in every 20 sample measurements.ResultsThe number of proteins identified was stable at approximately 3000 in five measurements of HVmix and DMmix, as quality control samples. The average coefficient of variation (CV) of the quantitative values was 12.6% for HVmix and 14.8% for DMmix. Approximately 90% of the proteins did not change significantly with age, while approximately 10% of the proteins increased or decreased with age. The quantitative values of some proteins, such as KLK3 in men and A2ML1 in women, differed significantly between the sexes. In addition, several proteins that have already been reported as biomarkers of kidney damage were also quantified.Conclusion(s)This study demonstrated that advanced proteomics enabled comprehensive quantification of urinary proteins, some proteins varied in abundance with age and gender, and provided insight into protein structure.
Advances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was analyzed using this method to confirm the depth of protein identification and quantitative stability, and to examine changes in abundance with age and sex, as well as the amounts of proteins known to be urinary biomarkers of kidney damage.BACKGROUNDAdvances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was analyzed using this method to confirm the depth of protein identification and quantitative stability, and to examine changes in abundance with age and sex, as well as the amounts of proteins known to be urinary biomarkers of kidney damage.Urine samples were collected from 89 healthy male and female volunteers in their 20s to 70s. Proteins were precipitated with methanol/chloroform, digested with trypsin, and peptides were identified and quantified by mass spectrometry. The quantitative relative value of a protein in the total protein was multiplied by 1,000,000 to obtain a normalized relative value (ppm). The stability of the quantitative proteomics was examined by measuring quality control samples prepared from healthy volunteer urine mix (HVmix) or diabetic urine mix (DMmix) 5 times in every 20 sample measurements.METHODSUrine samples were collected from 89 healthy male and female volunteers in their 20s to 70s. Proteins were precipitated with methanol/chloroform, digested with trypsin, and peptides were identified and quantified by mass spectrometry. The quantitative relative value of a protein in the total protein was multiplied by 1,000,000 to obtain a normalized relative value (ppm). The stability of the quantitative proteomics was examined by measuring quality control samples prepared from healthy volunteer urine mix (HVmix) or diabetic urine mix (DMmix) 5 times in every 20 sample measurements.The number of proteins identified was stable at approximately 3000 in five measurements of HVmix and DMmix, as quality control samples. The average coefficient of variation (CV) of the quantitative values was 12.6% for HVmix and 14.8% for DMmix. Approximately 90% of the proteins did not change significantly with age, while approximately 10% of the proteins increased or decreased with age. The quantitative values of some proteins, such as KLK3 in men and A2ML1 in women, differed significantly between the sexes. In addition, several proteins that have already been reported as biomarkers of kidney damage were also quantified.RESULTSThe number of proteins identified was stable at approximately 3000 in five measurements of HVmix and DMmix, as quality control samples. The average coefficient of variation (CV) of the quantitative values was 12.6% for HVmix and 14.8% for DMmix. Approximately 90% of the proteins did not change significantly with age, while approximately 10% of the proteins increased or decreased with age. The quantitative values of some proteins, such as KLK3 in men and A2ML1 in women, differed significantly between the sexes. In addition, several proteins that have already been reported as biomarkers of kidney damage were also quantified.This study demonstrated that advanced proteomics enabled comprehensive quantification of urinary proteins, some proteins varied in abundance with age and gender, and provided insight into protein structure.CONCLUSION(S)This study demonstrated that advanced proteomics enabled comprehensive quantification of urinary proteins, some proteins varied in abundance with age and gender, and provided insight into protein structure.
Background Advances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was analyzed using this method to confirm the depth of protein identification and quantitative stability, and to examine changes in abundance with age and sex, as well as the amounts of proteins known to be urinary biomarkers of kidney damage. Methods Urine samples were collected from 89 healthy male and female volunteers in their 20s to 70s. Proteins were precipitated with methanol/chloroform, digested with trypsin, and peptides were identified and quantified by mass spectrometry. The quantitative relative value of a protein in the total protein was multiplied by 1,000,000 to obtain a normalized relative value (ppm). The stability of the quantitative proteomics was examined by measuring quality control samples prepared from healthy volunteer urine mix (HVmix) or diabetic urine mix (DMmix) 5 times in every 20 sample measurements. Results The number of proteins identified was stable at approximately 3000 in five measurements of HVmix and DMmix, as quality control samples. The average coefficient of variation (CV) of the quantitative values was 12.6% for HVmix and 14.8% for DMmix. Approximately 90% of the proteins did not change significantly with age, while approximately 10% of the proteins increased or decreased with age. The quantitative values of some proteins, such as KLK3 in men and A2ML1 in women, differed significantly between the sexes. In addition, several proteins that have already been reported as biomarkers of kidney damage were also quantified. Conclusion(s) This study demonstrated that advanced proteomics enabled comprehensive quantification of urinary proteins, some proteins varied in abundance with age and gender, and provided insight into protein structure.
Author Yamamoto, Tadashi
Yamamoto, Keiko
Author_xml – sequence: 1
  givenname: Keiko
  surname: Yamamoto
  fullname: Yamamoto, Keiko
  email: yamamotok-bbc@ccr.niigata-u.ac.jp
  organization: Biofluid and Biomarker Center, Kidney Research Center, Environmental and Energy Science University Institute Center, Graduate School of Medical and Dental Sciences, Niigata University
– sequence: 2
  givenname: Tadashi
  orcidid: 0000-0001-9457-5582
  surname: Yamamoto
  fullname: Yamamoto, Tadashi
  organization: Biofluid and Biomarker Center, Kidney Research Center, Environmental and Energy Science University Institute Center, Graduate School of Medical and Dental Sciences, Niigata University, Clinical Laboratory, Shinrakuen Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39992494$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1PGzEQhi0EKgT6B3pAlrhw2eLP9fqIolKQkLjA2XLs2Y2jxAu2N1L-fU0CReqhh_GMpWfeGc07Q8dxjIDQD0p-UkLUTaaEStUQJmu0XDfsCJ1RwVWjlNbHteaCNVRJeopmOa8IIZ2W-hs65VprJrQ4Q9vbAbCNHg8QPSTsQ99Dgugg4xBxWQKeUog27fBrGguMG8Bjj5dg12W5w3larMCVjKcc4rDHrd_aWOxQBSr4NtVPKLaELXwqBJcv0Elv1xm-f-Rz9HL363l-3zw-_X6Y3z42jrO21FdLAG-JcC0RXlnKNGfdopOdooIpzV1rqdbedba1lknwTokFsaLXQraMn6Prg24d_TZBLmYTsoP12kYYp2w4VYSptmVdRa_-QVfjlGLdznDGhKKdZKRSlx_UtNiAN68pbOpxzOdFK8AOgEtjzgn6vwgl5t02c7DNVNvM3jbzviY_NOUKxwHS1-z_dP0B4BGagQ
Cites_doi 10.1074/mcp.RA119.001343
10.1074/mcp.R200007-MCP200
10.1038/s41592-020-00998-0
10.1681/ASN.2008070782
10.1016/j.ebiom.2023.104635
10.1159/000188509
10.3390/mps2020046
10.1016/j.cmet.2021.04.004
10.1046/j.1523-1755.2003.00868.x
10.1007/s10157-020-01920-w
10.1038/s41592-019-0638-x
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Japanese Society of Nephrology 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2025. The Author(s), under exclusive licence to Japanese Society of Nephrology.
Copyright Springer Nature B.V. Jul 2025
Copyright_xml – notice: The Author(s), under exclusive licence to Japanese Society of Nephrology 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2025. The Author(s), under exclusive licence to Japanese Society of Nephrology.
– notice: Copyright Springer Nature B.V. Jul 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
DOI 10.1007/s10157-025-02639-2
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1437-7799
EndPage 919
ExternalDocumentID 39992494
10_1007_s10157_025_02639_2
Genre Journal Article
GeographicLocations Japan
Germany
GeographicLocations_xml – name: Germany
– name: Japan
GrantInformation_xml – fundername: Tosoh
  funderid: http://dx.doi.org/10.13039/100018741
GroupedDBID ---
-Y2
-~C
.55
.86
.VR
06C
06D
0R~
0VY
1N0
1SB
203
29B
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
36B
4.4
406
408
409
40D
40E
53G
5GY
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACSTC
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
OVD
P9S
PF0
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
PZZ
Q2X
QOR
QOS
R89
R9I
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
X7M
YLTOR
Z45
ZMTXR
ZOVNA
~A9
AAYXX
CITATION
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7QP
K9.
7X8
ID FETCH-LOGICAL-c326t-c395eeda04c604d7a129328b8587142793c6a199dc8a6aa25edc74b0a4f945623
IEDL.DBID U2A
ISSN 1342-1751
1437-7799
IngestDate Fri Jul 11 11:09:18 EDT 2025
Sat Aug 16 21:26:03 EDT 2025
Mon Jul 21 06:04:36 EDT 2025
Thu Jul 03 08:46:43 EDT 2025
Sat Jun 28 01:12:08 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Urine
Biomarker
Quantitation
Proteomics
Language English
License 2025. The Author(s), under exclusive licence to Japanese Society of Nephrology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c326t-c395eeda04c604d7a129328b8587142793c6a199dc8a6aa25edc74b0a4f945623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9457-5582
PMID 39992494
PQID 3224718520
PQPubID 43386
PageCount 8
ParticipantIDs proquest_miscellaneous_3170276628
proquest_journals_3224718520
pubmed_primary_39992494
crossref_primary_10_1007_s10157_025_02639_2
springer_journals_10_1007_s10157_025_02639_2
PublicationCentury 2000
PublicationDate 2025-07-01
PublicationDateYYYYMMDD 2025-07-01
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
– name: Japan
– name: Tokyo
PublicationSubtitle Official Publication of the Japanese Society of Nephrology
PublicationTitle Clinical and experimental nephrology
PublicationTitleAbbrev Clin Exp Nephrol
PublicationTitleAlternate Clin Exp Nephrol
PublicationYear 2025
Publisher Springer Nature Singapore
Springer Nature B.V
Publisher_xml – name: Springer Nature Singapore
– name: Springer Nature B.V
References F Bienaim (2639_CR2) 2023; 93
F Meier (2639_CR5) 2020; 17
C Shao (2639_CR9) 2019; 18
M Hara (2639_CR3) 1995; 69
Y Mori (2639_CR10) 2021; 33
K Doi (2639_CR4) 2020; 24
V Demichev (2639_CR6) 2020; 17
S Saito (2639_CR7) 2019; 2
JS Nielsen (2639_CR11) 2009; 20
K Iseki (2639_CR1) 2003; 63
NL Anderson (2639_CR8) 2002; 1
References_xml – volume: 18
  start-page: 1110
  issue: 6
  year: 2019
  ident: 2639_CR9
  publication-title: Mol Cell Proteom
  doi: 10.1074/mcp.RA119.001343
– volume: 1
  start-page: 845
  issue: 11
  year: 2002
  ident: 2639_CR8
  publication-title: Mol Cell Proteom
  doi: 10.1074/mcp.R200007-MCP200
– volume: 17
  start-page: 1229
  issue: 12
  year: 2020
  ident: 2639_CR5
  publication-title: Nat Methods
  doi: 10.1038/s41592-020-00998-0
– volume: 20
  start-page: 1669
  issue: 8
  year: 2009
  ident: 2639_CR11
  publication-title: JASN
  doi: 10.1681/ASN.2008070782
– volume: 93
  year: 2023
  ident: 2639_CR2
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2023.104635
– volume: 69
  start-page: 397
  year: 1995
  ident: 2639_CR3
  publication-title: Nephron
  doi: 10.1159/000188509
– volume: 2
  start-page: 46
  issue: 2
  year: 2019
  ident: 2639_CR7
  publication-title: Methods Protoc
  doi: 10.3390/mps2020046
– volume: 33
  start-page: 1042
  issue: 5
  year: 2021
  ident: 2639_CR10
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2021.04.004
– volume: 63
  start-page: 1468
  year: 2003
  ident: 2639_CR1
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00868.x
– volume: 24
  start-page: 979
  issue: 11
  year: 2020
  ident: 2639_CR4
  publication-title: Clin Exp Nephrol
  doi: 10.1007/s10157-020-01920-w
– volume: 17
  start-page: 41
  issue: 1
  year: 2020
  ident: 2639_CR6
  publication-title: Nat Methods
  doi: 10.1038/s41592-019-0638-x
SSID ssj0008959
Score 2.3747387
Snippet Background Advances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers...
Advances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was...
BackgroundAdvances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 912
SubjectTerms Adult
Age
Age Factors
Aged
Aging - urine
Biomarkers
Biomarkers - urine
Chloroform
Diabetes mellitus
Female
Females
Gender
Gender differences
Healthy Volunteers
Humans
Kallikreins
Kidneys
Laboratories
Male
Mass spectroscopy
Medicine
Medicine & Public Health
Middle Aged
Nephrology
Original Article
Protein structure
Proteome
Proteomes
Proteomics
Proteomics - methods
Quality control
Sex differences
Sex Factors
Trypsin
Urine
Urology
Young Adult
Title Age and gender differences in the urinary proteome of healthy subjects using the advantages of quantitative proteomics
URI https://link.springer.com/article/10.1007/s10157-025-02639-2
https://www.ncbi.nlm.nih.gov/pubmed/39992494
https://www.proquest.com/docview/3224718520
https://www.proquest.com/docview/3170276628
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NS8MwFH_IBuJF1PlRnRJBvGihTZN-HIuoQ5knB3oqSZqNHdbpugn7731J26lMD156aUhKf8l775f3BXDBhI6lRpJDaR65THnclXHC3IDJUMlIR0FgEoX7T2FvwB5e-EudFFY20e6NS9JK6m_Jbj6PXNN-FXlDkLgoeNvccHfcxQOaruRvnNgWaX7AqIvK0a9TZX6f46c6WrMx1_yjVu3c7cB2bS-StAJ4FzZ0sQedtECuPFmSS2IjOO3V-B5s9mtHeQc-0pEmosjJyLaKI00fFJQKZFwQtPqIuWYXsyWxlRqmE02mQ1JlRS5JuZDmfqYkJix-ZIfbYIE5Sp_SDHxfiMKmp6GwbGYYq3IfBne3zzc9t26x4Cq02-b4TDhqSeExFXosj4RR_zSWMUcixSgeXhUKP0lyFYtQCMp1riImPcGGieFOwQG0immhj4AohUwS5UUYKMm09kzlP6lzriQaSVxoB66aP529VZU0sq-ayQaXDHHJLC4ZdaDbgJHVp6rMUPgYXYqgO3C-eo3nwTg5RKGnCxyDy9IoDGnswGEF4mo5NMYM3WQOXDeofk3-97cc_2_4CWxRu8NMTG8XWvPZQp-i5TKXZ9BO718fb8_shv0EtBvmDg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV07T8MwED6hIgELAsojPI2EWCBS6th5jBWiKo8ytVK3yHbcqkMTaFqk_nvObtKCCgNLllh2lLO_-873ArhhQkdSo5FDaRq6THnclVHMXJ_JQMlQh75vEoU7b0G7x577vF8mhRVVtHvlkrRI_S3ZrcFD17RfRbvBj10E3k0kA5EJ5OrR5hJ_o9i2SGv4jLqoHBtlqszvc_xUR2scc80_atVOaw92S75ImgsB78OGzg6g3szQVh7PyS2xEZz2avwAtjqlo7wOn82hJiJLydC2iiNVHxREBTLKCLI-Yq7ZxWRObKWGfKxJPiCLrMg5KWbS3M8UxITFD-1wGywwRfQpzMCPmchsehqCZTXDSBWH0Gs9dh_abtliwVXI26b4jDlqSeExFXgsDYVR_zSSEUdDilE8vCoQjThOVSQCISjXqQqZ9AQbxMZ28o-gluWZPgGiFFqSiBeBryTT2jOV_6ROuZJIkrjQDtxVfzp5X1TSSFY1k41cEpRLYuWSUAfOK2Ek5akqEgQfo0s59Ry4Xr7G82CcHCLT-QzH4LI0DAIaOXC8EOJyOSRjxtxkDtxXUl1N_ve3nP5v-BVst7ud1-T16e3lDHao3W0mvvccatPJTF8gi5nKS7tpvwB5FOdt
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEB5EQbyIb-szgnjRYpsmfRwXdfGNBxe8lSTNLnswq7Yr7L93kraroh689NKQlE7yzTeZF8AhEzqVGo0cSovEZyrgvkwz5kdMxkomOokimyh8dx9f9tj1E3_6ksXvot1bl2Sd02CrNJnq9KXon35JfAt54ttWrGhDRJmPIDyHcBzafd2jnSkWp5lrlxZGjPqoKMMmbeb3Ob6rph9884ev1Kmg7hIsNtyRdGphL8OMNiuw2jFoNz9PyBFx0ZzumnwF5u8ap_kqvHcGmghTkIFrG0faniiIEGRoCDJAYq_cxduEuKoNo2dNRn1SZ0hOSDmW9q6mJDZEfuCGu8CBCpGotANfx8K4VDUEznaGoSrXoNe9eDy79Jt2C75CDlfhM-OoMUXAVBywIhGWCtBUphyNKkbxIKtYhFlWqFTEQlCuC5UwGQjWz6wdFa3DrBkZvQlEKbQqETviSEmmdWCrAEpdcCWRMHGhPThu_3T-UlfVyD_rJ1u55CiX3Mklpx7stMLImxNW5ghEVq9yGnhwMH2NZ8M6PITRozGOwWVpEsc09WCjFuJ0OSRm1vRkHpy0Uv2c_O9v2frf8H2Yfzjv5rdX9zfbsEDdZrOhvjswW72N9S4SmkruuT37Ad3W66k
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Age+and+gender+differences+in+the+urinary+proteome+of+healthy+subjects+using+the+advantages+of+quantitative+proteomics&rft.jtitle=Clinical+and+experimental+nephrology&rft.au=Yamamoto%2C+Keiko&rft.au=Yamamoto%2C+Tadashi&rft.date=2025-07-01&rft.eissn=1437-7799&rft.volume=29&rft.issue=7&rft.spage=912&rft_id=info:doi/10.1007%2Fs10157-025-02639-2&rft_id=info%3Apmid%2F39992494&rft.externalDocID=39992494
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1342-1751&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1342-1751&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1342-1751&client=summon